Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Jan 22, 2021 54.78 -0.96   
 Ackermans & van Haaren NV ACKB Jan 22, 2021 131.10 -0.30   
 Aedifica SA AED Jan 22, 2021 99.00 +2.48   
 Ageas AGS Jan 22, 2021 43.86 -1.81   
 APERAM APAM Jan 22, 2021 36.79 -0.84   
 Argen X SE ARGX Jan 22, 2021 254.60 +0.16   
 Barco NV BAR Jan 22, 2021 17.35 -4.96   
 Bel20 BEL20 Jan 22, 2021 3 743.25 -0.74   
 Cofinimmo COFB Jan 22, 2021 123.80 +0.49   
 Colruyt SA COLR Jan 22, 2021 50.40 0.00   
 GALAPAGOS GLPG Jan 22, 2021 89.56 -2.12   
 Groupe Bruxelles Lambert SA GBLB Jan 22, 2021 84.38 -0.87   
 ING GROEP N.V. INGA Jan 22, 2021 7.71 -1.48   
 KBC Groep NV KBC Jan 22, 2021 59.30 -0.87   
 Proximus SADP PROX Jan 22, 2021 17.36 +0.40   
 Sofina SA SOF Jan 22, 2021 274.50 +0.73   
 Solvay SA SOLB Jan 22, 2021 98.28 -1.48   
 Telenet Group Holding NV TNET Jan 22, 2021 37.04 -0.43   
 UCB SA UCB Jan 22, 2021 87.58 +0.62   
 Umicore SA UMI Jan 22, 2021 47.56 -2.10   
 Warehousing & Distribution De Pauw WDP Jan 22, 2021 29.36 +0.76   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK